大动脉炎患者内皮细胞中mTOR通路被激活并受血清免疫球蛋白G调节
研究探讨mTOR通路在大血管炎中的作用,对TA和GCA患者的主动脉及颞动脉活检组织进行免疫荧光分析。结果发现mTORC1和mTORC2仅在TA患者内皮细胞中特异性激活,TA患者血清中抗内皮细胞抗体水平高于GCA患者和健康对照,纯化IgG可诱导内皮细胞mTORC1激活和显著增殖,西罗莫司可减弱该效应。结论提示TA中抗内皮细胞抗体通过激活mTOR通路驱动内皮重塑,抑制mTOR通路可能为TA治疗选择。
要点
- mTORC1和mTORC2仅在TA患者内皮细胞中激活,GCA患者和健康对照中未见。
- TA患者抗内皮细胞抗体水平高于GCA患者和健康对照。
- TA患者纯化IgG诱导内皮细胞mTORC1激活和显著增殖,西罗莫司可减弱此效应。
核心结论
- 结果提示靶向内皮细胞的抗体通过激活mTOR通路驱动TA中的内皮重塑,而在GCA中并非如此。
- 抑制mTOR通路可能代表TA的一种治疗选择。
研究设计与样本
- 对TA和GCA患者的主动脉及颞动脉活检组织进行免疫荧光分析,评估mTOR通路参与情况。
- 通过免疫荧光和细胞ELISA检测血清中靶向内皮细胞的抗体。
- 体外评估患者纯化IgG对mTOR通路激活和细胞增殖的影响。
主要发现
- 免疫荧光分析显示mTORC1和mTORC2仅在TA患者内皮细胞中特异性激活,GCA患者和健康对照的内皮细胞中未激活。
- 免疫荧光和ELISA显示TA患者抗内皮细胞抗体水平高于GCA患者和健康对照。
- Western blot显示TA患者纯化IgG引起内皮细胞mTORC1激活,而GCA患者或健康对照的纯化IgG未观察到该效应。
- TA患者纯化IgG诱导显著的内皮细胞增殖,与GCA和健康对照IgG相比;内皮细胞暴露于西罗莫司(特异性mTOR抑制剂和PI3K抑制剂)后该效应减弱。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Takayasu arteritis (TA) and GCA are large-vessel vasculitides characterized by vascular remodelling involving endothelial cells (ECs) and vascular smooth muscle cells. Mammalian target of rapamycin (mTOR) pathway has been involved in vascular remodelling. We hypothesized that the mTOR pathway was involved in the pathogenesis of large-vessel vasculitis. METHODS: We used IF analysis on aortic and temporal artery biopsies from patients with TA and GCA to assess the involvement of the mTOR pathway and searched for antibodies targeting ECs in serum by IIF and cellular ELISA. We evaluated in vitro the effect of purified IgG from patients on mTOR pathway activation and cell proliferation. RESULTS: IF analyses on tissues revealed that both mTORC1 and mTORC2 are activated specifically in ECs from TA patients but not in ECs from GCA patients and healthy controls (HCs). Using IIF and ELISA, we observed higher levels of antibodies binding to ECs in TA patients compared with GCA patients and HCs. Using western blot, we demonstrated that purified IgG from TA patients caused mTORC1 activation in ECs, whereas this effect was not observed with purified IgG from GCA patients or HCs. Purified IgG from TA patients induced a significant EC proliferation compared with to GCA and HC IgG, and this effect was decreased after EC exposure with sirolimus, a specific mTOR inhibitor and PI3K inhibitor. CONCLUSION: Our results suggest that antibodies targeting ECs drive endothelial remodelling in TA through activation of the mTOR pathway, but not in GCA. Inhibition of the mTOR pathway could represent a therapeutic option in TA.
引用
- Hadjadj J, Canaud G, Mirault T, et al. mTOR pathway is activated in endothelial cells from patients with Takayasu arteritis and is modulated by serum immunoglobulin G. Rheumatology (Oxford). 2018. PMID: 29506143. doi:10.1093/rheumatology/key017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。